EVAMPLIX Trademark

Trademark Overview

On Monday, January 14, 2019, a trademark application was filed for EVAMPLIX with the United States Patent and Trademark Office. The USPTO has given the EVAMPLIX trademark a serial number of 88260718. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 5, 2022. This trademark is owned by Agenus Inc.. The EVAMPLIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
evamplix

General Information

Serial Number88260718
Word MarkEVAMPLIX
Filing DateMonday, January 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
Translation of Words in MarkThe word(s) "EVAMPLIX" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgenus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameAgenus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, December 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 4, 2022SOU EXTENSION 5 GRANTED
Thursday, April 28, 2022SOU EXTENSION 5 FILED
Wednesday, May 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2021SOU EXTENSION 4 GRANTED
Friday, October 29, 2021SOU EXTENSION 4 FILED
Friday, October 29, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 26, 2021SOU EXTENSION 3 GRANTED
Monday, April 26, 2021SOU EXTENSION 3 FILED
Monday, April 26, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020SOU EXTENSION 2 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 2 FILED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 21, 2020SOU EXTENSION 1 GRANTED
Tuesday, April 21, 2020SOU EXTENSION 1 FILED
Tuesday, April 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 6, 2019ASSIGNED TO LIE
Monday, July 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 28, 2019NON-FINAL ACTION E-MAILED
Thursday, March 28, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 27, 2019ASSIGNED TO EXAMINER
Wednesday, February 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

evamplix diseases disorders transplant rejections inflammatory infectious autoimmune cancer treatment preparations